Preventive approaches in chronic liver diseases, part I

Mohammad R. Taheri, Thomas R. Riley

Research output: Contribution to journalReview articlepeer-review

Abstract

Hepatitis C virus is the leading cause of chronic liver disease (CLD) worldwide and non-alcoholic fatty liver disease in the western world. Preventive measures can significantly reduce the progression of liver disease to cirrhosis and liver cancer. This review will discuss preventive measures with proven benefits. Alcohol abstinence is recommended to patients with CLD. Immunization for hepatitis A and B should be provided to patients with CLD. Medications and herbals should be used carefully in these patients to avoid potential hepatotoxicity. Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided and acetaminophen is safe at doses of less than 2 grams daily. Weight control and regular exercise is recommended in patients with CLD. Part II and III will address preventive approaches in those with compensated hepatic cirrhosis and decompensated cirrhosis respectively.

Original languageEnglish (US)
Pages (from-to)51-52+54-60
JournalPractical Gastroenterology
Volume32
Issue number4
StatePublished - Apr 2008

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Fingerprint Dive into the research topics of 'Preventive approaches in chronic liver diseases, part I'. Together they form a unique fingerprint.

Cite this